Precigen (PGEN) Receivables - Net (2012 - 2026)
Precigen (PGEN) posted quarterly Receivables - Net of $26.4 million for Q1 2026, up 3415.71% year-over-year from $751000.0 in Q1 2025, and up 574.23% quarter-over-quarter from $3.9 million in Q4 2025.
Precigen (PGEN) Receivables - Net (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Receivables - Net for 15 consecutive years, with $26.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 3415.71% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $26.4 million (up 3415.71% YoY), while the FY2025 annual figure was $3.9 million, up 322.89% from the prior year.
- Receivables - Net rose to $26.4 million in Q1 2026 per PGEN's latest filing, from $3.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $26.4 million in Q1 2026 and bottomed at $327000.0 in Q2 2025.
- Historically, Receivables - Net has averaged $4.0 million across 5 years, with a median of $978000.0 in 2022.
- Annual changes were most pronounced in 2022 — Receivables - Net sank 94.98% — and 2026, when it jumped 3415.71%.
- Precigen's Receivables - Net stood at $978000.0 in 2022, then fell by 7.77% to $902000.0 in 2023, then rose by 2.66% to $926000.0 in 2024, then surged by 322.89% to $3.9 million in 2025, then surged by 574.23% to $26.4 million in 2026.
- Business Quant data shows PGEN's Receivables - Net at $26.4 million in Q1 2026, $3.9 million in Q4 2025, and $580000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.87 Mn |
| Jun 30, 2026 | 71.87 Mn |
| Mar 31, 2026 | 26.40 Mn |
| Mar 31, 2026 | 26.40 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Sep 30, 2025 | 580,000.00 |
| Sep 30, 2025 | 580,000.00 |
| Jun 30, 2025 | 327,000.00 |
| Jun 30, 2025 | 327,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Dec 31, 2024 | 926,000.00 |
| Dec 31, 2024 | 926,000.00 |
| Sep 30, 2024 | 479,000.00 |
| Sep 30, 2024 | 479,000.00 |
| Jun 30, 2024 | 511,000.00 |
| Jun 30, 2024 | 511,000.00 |
| Mar 31, 2024 | 872,000.00 |
| Mar 31, 2024 | 872,000.00 |